SFM
AMPH icon

Signet Financial Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Signet Financial Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,926
Closed -$45K – 302
2021
Q4 		$45K Buy
+1,926
New +$39.4K 0.01% 507

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Signet Financial Management's AMPH Position: Q1 2022 in Review

Signet Financial Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2022, closing a stake of 1,926 shares — an estimated $45K sold.

Signet Financial Management first reported a position in AMPH in Q4 2021 and held it in 1 quarter. The position peaked at $45K in Q4 2021. 203 funds tracked by Wall St. Rank hold AMPH as of Q1 2022.

  • Signet Financial Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Signet Financial Management sold 1,926 Amphastar Pharmaceuticals shares in Q1 2022, an estimated $45K.
  • Signet Financial Management first reported a position in Amphastar Pharmaceuticals in Q4 2021 and held it in 1 quarter.
  • Signet Financial Management's Amphastar Pharmaceuticals position peaked at $45K in Q4 2021.
  • 203 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2022.

Based on Signet Financial Management's 13F filing for Q1 2022, filed 13 May 2022.